Drug intelligence / Profile preview

Huazhuo Sanjie Zhubi

Development stage: Preclinical
Administration: Oral

Overview

Huazhuo Sanjie Zhubi is a traditional Chinese medicine (TCM) formulation, most commonly available as granules. It is used in combination with allopurinol for the treatment of chronic gouty arthritis. The precise herbal composition and mechanism of action are not specified in the available sources, but TCM formulations like this typically aim to reduce inflammation and modulate immune responses according to TCM theory. Its use is being evaluated in clinical trials for efficacy and safety in gout management[1].

Brand names: Huazhuo Sanjie Zhubi
Other names: Huazhuo Sanjie Zhubi granules

Beyond the preview

Go deeper on Huazhuo Sanjie Zhubi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huazhuo Sanjie Zhubi.

Explore the full profile